Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Feb 17 8:30am

PSC Epidemiology and Outcomes in a Population-based Cohort

By Ethan McConkey, Moderator, @ethanmcconkey

2020-02-07 Epidemiology image

In a recent paper published in the Journal of Gastroenterology, Bakhshi et al., reported an update on the epidemiology and outcomes of Primary Sclerosing Cholangitis (PSC) in a population-based cohort. The authors found that the incidence (i.e., the occurrence of new cases per year) of PSC almost doubled from 2001 to 2017 compared to the period from 1976 to 2000. Importantly, patients with PSC were increasingly being diagnosed with milder disease. The intra-individual variation of serum alkaline phosphatase was high, thus,  questioning the use of this biochemical marker as an endpoint in clinical trials.

Read the paper from Dr. Bakhshi

Join others discussing PSC

I was not part of this research because of not being a resident in Olmstead County. However, I did get my transplant for PSC at Mayo Rochester, after being sent there by my local providers to meet with the experts. I enjoy reading about the research related to PSC, and I feel good knowing that my own experience and records are part of other and ongoing research at Mayo.

COMMENT
Please login or register to post a reply.

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

Please login or register to send an invite.